| Literature DB >> 26715186 |
D Fietz1, M Markmann2, D Lang3, L Konrad4, J Geyer5, S Kliesch6, T Chakraborty7, H Hossain8, M Bergmann9.
Abstract
BACKGROUND: Androgens play an important role for the development of male fertility and gained interest as growth and survival factors for certain types of cancer. Androgens act via the androgen receptor (AR/Ar), which is involved in various cell biological processes such as sex differentiation. To study the functional mechanisms of androgen action, cell culture systems and AR-transfected cell lines are needed. Transfection of AR into cell lines and subsequent gene expression analysis after androgen treatment is well established to investigate the molecular biology of target cells. However, it remains unclear how the transfection with AR itself can modulate the gene expression even without androgen stimulation. Therefore, we transfected Ar-deficient rat Sertoli cells 93RS2 by electroporation using a full length human AR.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26715186 PMCID: PMC4696255 DOI: 10.1186/s12867-015-0051-7
Source DB: PubMed Journal: BMC Mol Biol ISSN: 1471-2199 Impact factor: 2.946
Fig. 1Expression of androgen receptor (Ar) mRNA in Sertoli cell cultures. To find an appropriate cell culture system for our planned transfection studies, RT-PCR with specific primers for mouse and rat Ar was performed. Testis homogenate from rat and mouse served as positive control, whereas water was used as no template control (NTC) samples. We tested two mouse (WL3 and SK-11) as well as two rat Sertoli cell lines (SCIT-C8 and 93RS2). The latter revealed no expression of intrinsic Ar and were therefore used for further experiments
Fig. 2Transfection control of 93RS2 Sertoli cells. a 24 h after transfection, transfected (a) and non-transfected (b) cells as negative control were fixed for IF experiments. left Incubation with rabbit anti-GFP antibody showed successful transfection of almost 80 % of cells. right No staining signal was detectable in non-transfected cells. Scale bars in main image: 200 µm, detail: 25 µm. DAPI counterstain. b Western Blot analysis revealed AR protein in transfected Sertoli cells at approx. 135 kDa (1) and in human testis tissue at the expected molecular weight of 110 kDa (2). The higher protein weight measured in transfected cells is due to coupling of AR with GFP. c Expression of human AR mRNA was tested in human testis homogenate (1), transfected (2) and non-transfected cells (3). AR mRNA was detected in the positive control and transfected 93RS2hAR17 cells, but not in non-transfected cells and the NTC (lane 4). d To control the CAG repeat length in transfected 93RS2 cells, we performed high-resolution PAGE. Three different passages of 93RShAR17 cells (lanes 1–3) were analysed and revealed a band for human AR at 185 bp by using two different DNA ladders. By sequencing, 185 bp was shown to be typical for the presence of 17 CAG repeats. Lane 4 no template control (NTC)
Fig. 3Hierarchical clustering of 672 significantly altered genes. Genes are depicted in rows and samples in columns. Blue indicates downregulation whereas red shows upregulation. Clustering was done using “Pearson correlation” and “complete linkage”. The tree on the left reflects the distances between gene profiles based on this algorithm
Overview of ten highest ranked up- and down-regulated genes
| Regulation | Identifier | Symbol | EntrezID | FDR | FC | Gene name | Comment |
|---|---|---|---|---|---|---|---|
| Down | Idx_R307_C32 |
| 295,669 | 0.001 | −107,712 | Cytochrome b reductase 1 | Expression of the ferric reductase is regulated by intracellular iron concentration and other facilitators of iron absorption, indicating that it responds to iron demand |
| Down | Idx_R293_C42 |
| 286,978 | 0.003 | −71,936 | Thymosin beta-like protein 1 | Actin cytoskeleton organization |
| Down | Idx_R29_C52 |
| 94,270 | 0.001 | −50,214 | Neuronatin | The effects of Nnat on inflammatory pathways in vitro and in vivo suggest a pathophysiological role of this new gene in diabetic vascular diseases |
| Down | Idx_R245_C71 |
| 300,870 | 0.006 | −42,921 | Family with sequence similarity 46, member A | |
| Down | Idx_R259_C49 |
| 252,929 | 0.003 | −39,163 | Cathepsin Z | Accounts for the lysosome’s capacity to digest polyQ sequences. Cathepsins L and Z are important in defending against the accumulation and toxicity of polyQ proteins |
| Down | Idx_R322_C43 |
| 85,267 | 0.003 | −38,220 | Solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 | |
| Down | Idx_R196_C66 |
| 361,413 | 0.004 | −36,487 | Nudix (nucleoside diphosphate linked moiety X)-type motif 7 | |
| Down | Idx_R200_C18 |
| 309,375 | 0.001 | −34,855 | MARVEL domain containing 1 | |
| Down | Idx_R240_C21 |
| 83,534 | 0.001 | −32,489 | Tripeptidyl peptidase I | |
| Down | Idx_R245_C74 |
| 83,534 | 0.001 | −31,626 | Tripeptidyl peptidase I | |
| Down | Idx_R47_C36 |
| 317,407 | 0.001 | −30,042 | Basic helix-loop-helix domain containing, class B, 9 | |
| Up | Idx_R117_C7 |
| 293,624 | 0.003 | 5540 | Interferon regulatory factor 7 | The crucial regulator of type I interferons (IFNs) against pathogenic infections, which activate IRF7 by triggering signaling cascades from pathogen recognition receptors (PRRs) that recognize pathogenic nucleic acids |
| Up | Idx_R14_C99 |
| 503,164 | 0.003 | 5611 | Apolipoprotein L 9a | |
| Up | Idx_R252_C110 |
| 312,688 | 0.003 | 5976 | Ubiquitin specific peptidase 18 | |
| Up | Idx_R317_C53 |
| 312,688 | 0.003 | 6264 | Ubiquitin specific peptidase 18 | |
| Up | Idx_R74_C32 |
| 171,059 | 0.004 | 6291 | WAP four-disulfide core domain 18 | |
| Up | Idx_R53_C102 |
| 304,053 | 0.001 | 6479 | Receptor-interacting serine-threonine kinase 4 | |
| Up | Idx_R278_C80 |
| 116,637 | 0.006 | 7177 | Chemokine (C–C motif) ligand 4 | |
| Up | Idx_R188_C91 |
| 246,268 | 0.003 | 7827 | 2–5 oligoadenylate synthetase 1B | |
| Up | Idx_R192_C96 |
| 294,075 | 0.004 | 9720 | Free fatty acid receptor 4 | |
| Up | Idx_R299_C11 |
| 361,749 | 0.002 | 9759 | Interleukin 33 | IL-33 is a dual function protein that may function as a proinflammatory cytokine and an intracellular nuclear factor with transcriptional regulatory properties |
| Up | Idx_R66_C107 |
| 361,749 | 0.001 | 10,690 | Interleukin 33 | |
| Up | Idx_R102_C39 |
| 24,575 | 0.004 | 12,708 | Myxovirus (influenza virus) resistance 1 | The human myxovirus resistance protein 1 is a key mediator of the interferon-induced antiviral response against a wide range of viruses. MxA may form oligomeric rings around tubular nucleocapsid structures. As a consequence, these viral components are trapped and sorted to locations where they become unavailable for the generation of new virus particles |
Overview of functional gene ontology categories according to their pattern of significantly regulated genes
| Group | Cluster# | Cluster of GO categories | Score | Symbols | |
|---|---|---|---|---|---|
| Cell development/cell contact [106] | 1 | Biological adhesion (4) [25] | 2.27 | Up |
|
| Down |
| ||||
| 3 | Axonogenesis (13) [36] | 1.89 | Up |
| |
| Down |
| ||||
| 4 | Retinoid metabolic process (5) [8] | 1.75 | Up |
| |
| Down |
| ||||
| 7 | Epithelium development (15) [50] | 1.47 | Up |
| |
| Down |
| ||||
| H [36] | 2 | Response to steroid hormone stimulus (10) [36] | 1.90 | Up |
|
| Down |
| ||||
| Immune response [55] | 5 | Innate immune response (4) [34] | 1.69 | Up |
|
| Down |
| ||||
| 8 | Cell surface receptor linked signal transduction (3) [25] | 1.35 | Up |
| |
| Down |
| ||||
| N [12] | 6 | Nucleotide catabolic process (7) [12] | 1.47 | Up |
|
| Down |
|
Numbers in normal brackets denote the number of grouped GO categories. Absolute numbers of regulated genes per main group are given in squared brackets, examples of regulated genes are shown for up- and down-regulated genes
H hormone stimulus, N Nucleotide Catabolic Process
Upstream regulator analysis with IPA: types of predicted upstream regulators
| Activation (n = 51) | Inhibition (n = 20) | ||
|---|---|---|---|
| Cytokines/group of cytokines | 14 | Transcription regulator | 8 |
| Others/complex of others | 8 | Cytokine | 2 |
| Kinases, group of kinases | 8 | Enzyme | 2 |
| Growth factors/complex of growth factors | 6 | Other | 2 |
| Transcription regulator | 6 | G-protein coupled receptor | 1 |
| Transmembrene receptors | 4 | Growth factor | 1 |
| Enzymes | 3 | Ligand-dependent nuclear receptor | 1 |
| Ligand-dependent nuclear receptor | 1 | Peptidase | 1 |
| Peptidase | 1 | Phosphatase | 1 |
| Transporter | 1 | ||
Summarizing the regulator according to their type revealed a high proportion of possibly activated cytokines, whereas transcription regulators play a major role in inhibition
Based on gene expression patterns, predictions are made on activation or inactivation of known upstream regulators. Absolute activation z-scores of higher than 2.0 are considered to be highly significant. We found more than twice as much regulators predicted to be activated as compared to inhibited. These tables show the predicted upstream regulators with an absolute z-score above 2.0 in detail—some are in fact complexes or groups. The prediction is opposed to the real measurement on the micro array (rightmost columns), as far as the respective genes have passed QC and is otherwise marked as “not measured”. Mean expression per group is given as logarithm of the intensity to base 2. Reasonably high expression values are in bold face. The column “regulation AR17” denotes if the respective gene is contained in the set of regulated genes (level = L1) or at least close to significance (level = L2/L3) which holds true for the minority of genes. Activation or inhibition is not necessarily reflected by significant change of gene expression, since processes not measurable on a micro array, like for example phosphorylation, are more likely to be responsible for that
Upstream regulator analysis with IPA: proportion of up- and downregulated genes
| Gene pattern | Activation only | Inhibition only | Both |
|---|---|---|---|
| Down regulation | 64 | 28 | 50 |
| Up regulation | 28 | 5 | 45 |
The gene expression patterns upon which the prediction is made is constituted by both up-regulated and down-regulated genes. The predicted activation and inhibition is either based on two third down regulated (n = 114/n = 78) and one third upregulated genes (n = 73/n = 50). 50 downregulated genes and 45 upregulated genes contribute likewise to activation and inhibition (The details of the contributing gens are not shown here)
Based on gene expression patterns, predictions are made on activation or inactivation of known upstream regulators. Absolute activation z-scores of higher than 2.0 are considered to be highly significant. We found more than twice as much regulators predicted to be activated as compared to inhibited. These tables show the predicted upstream regulators with an absolute z-score above 2.0 in detail—some are in fact complexes or groups. The prediction is opposed to the real measurement on the micro array (rightmost columns), as far as the respective genes have passed QC and is otherwise marked as “not measured”. Mean expression per group is given as logarithm of the intensity to base 2. Reasonably high expression values are in bold face. The column “regulation AR17” denotes if the respective gene is contained in the set of regulated genes (level = L1) or at least close to significance (level = L2/L3) which holds true for the minority of genes. Activation or inhibition is not necessarily reflected by significant change of gene expression, since processes not measurable on a micro array, like for example phosphorylation, are more likely to be responsible for that
Upstream regulator analysis with IPA: predicted activated regulators
| IPA–prediction | Micro array analysis | ||||||
|---|---|---|---|---|---|---|---|
| Upstream regulator | Molecule type | z-score | FDR | FC | Mean AR17 | Mean noAR | Regulation AR17 [level] |
|
| Ligand-dependent nuclear receptor |
| 0.895 | −1.017 | −1.219 | −1.194 | |
|
| Growth factor |
| 0.011 | −1.483 |
|
| |
|
| Cytokine |
| 0.016 | 2.529 |
|
| [Up L3] |
|
| Enzyme |
| 0.019 | 2.096 |
|
| [Up L3] |
|
| Other |
| 0.010 | −1.656 |
|
| [Down L2] |
|
| Growth factor |
|
| ||||
|
| Group of kinases (n=7) |
|
| ||||
|
| Kinase | 0.009 | −1.019 |
|
| ||
|
| Kinase | 0.027 | −1.280 |
|
| ||
|
| Kinase | 0.701 | 1.086 | −2.321 | −2.440 | ||
|
| Kinase | 0.037 | 1.131 |
|
| ||
|
| Kinase | 0.758 | −1.047 |
|
| ||
|
| Kinase | 0.018 | −2.005 | 0.121 | 1.125 | [Down L3] | |
|
| Kinase | 0.208 | 1.217 |
| 0.224 | ||
|
| Group of kinases (n=7) |
|
| ||||
|
| Kinase | 0.105 | 1.182 |
|
| ||
|
| Kinase | 0.177 | 1.090 |
|
| ||
|
| Kinase | −1.066 | −0.092 |
|
| ||
|
| Kinase | 1.023 | 0.032 |
|
| ||
|
| Kinase | −1.058 | −0.082 |
|
| ||
|
| Kinase | 1.177 | 0.235 |
|
| ||
|
| Kinase | −1.125 | −0.170 | −1.445 | −1.275 | ||
|
| Group of kinases (n= 5) |
|
| ||||
|
| Kinase | 0.009 | −1.019 |
|
| ||
|
| Kinase | 0.087 | −1.343 | 0.139 |
| ||
|
| Kinase |
| |||||
|
| Kinase |
| |||||
|
| Kinase | 0.046 | −1.276 |
|
| ||
|
| Kinases (n= 2) |
|
| ||||
|
| Kinase |
| |||||
|
| Kinase |
| |||||
|
| Peptidase |
|
| ||||
|
| Growth factor |
| 0.122 | 1.178 | 0.417 | 0.180 | |
|
| Transcription regulator |
| 0.069 | −1.425 |
|
| |
|
| Enzyme |
|
| ||||
|
| Group of groups | ||||||
|
| Group of cytokines |
|
| ||||
|
| Group of cytokines |
|
| ||||
|
| Cytokine | 0.104 | 1.306 |
|
| ||
|
| Cytokine |
|
| ||||
|
| Cytokine |
|
| ||||
|
| cyTokine (n=4) |
| |||||
|
| Cytokine (n=6) |
| |||||
|
| Cytokine |
| |||||
|
| Cytokine |
| |||||
|
| Cytokine |
| |||||
|
| Group of cytokines (n=2) |
| |||||
|
| Cytokine |
| 0.079 | 2.953 | −1.949 | −3.511 | |
|
| Cytokine |
| 0.014 | 1.481 | −0.730 | −1.296 | |
|
| Group of transmembrane receptors |
|
| ||||
|
| Transmembrane receptor |
| |||||
|
| Transmembrane receptor |
| |||||
|
| Cytokine |
| | ||||
|
| Cytokine |
|
| ||||
|
| Cytokine |
|
| ||||
|
| Growth factor |
| 0.001 | −9.285 |
|
| [Down L1] |
|
| Kinase |
| 0.013 | −2.034 | −1.262 | −0.238 | [Down L3] |
|
| Cytokines (n=11) |
| |||||
|
| Cytokine |
| |||||
|
| Cytokine |
| 0.300 | −1.056 |
|
| |
|
| Cytokine | 0.689 | 1.102 | −2.284 | −2.424 | ||
|
| Cytokine | 0.009 | 1.812 | 0.062 | −0.796 | [Up L2] | |
|
| Cytokine | 0.001 | 10.690 |
| −1.420 | [Up L1] | |
|
| Cytokine |
| |||||
|
| Cytokine |
| |||||
|
| Cytokine |
| |||||
|
| Cytokine |
| |||||
|
| Cytokine | 0.019 | 1.393 |
|
| ||
|
| Cytokine |
| |||||
|
| Transcription regulator |
| 0.520 | 1.336 |
|
| |
|
| Transcription regulator |
| 0.113 | 1.096 |
|
| |
|
| Transcription regulator |
| 0.003 | 5.540 |
|
| [Up L1] |
|
| Enzyme |
| 0.191 | −1.097 |
|
| |
|
| Complex |
| |||||
|
| Other | 0.480 | 1.044 |
|
| ||
|
| Other | 0.251 | 1.273 | −0.193 | −0.541 | ||
|
| Kinase |
| 0.352 | −1.067 |
|
| |
|
| Other |
| 0.021 | −1.231 |
|
| |
|
| Complex |
| <group> | ||||
|
| Growth factor | 1.156 |
|
| |||
|
| Other |
| 0.003 | 1.346 |
|
| |
|
| Other |
|
| ||||
|
| Other |
|
| ||||
|
| Kinase |
| 0.611 | 1.237 | −0.033 | −0.341 | |
|
| Kinase |
| 0.033 | 1.348 |
|
| |
|
| Transcription regulator |
| 0.013 | 1.375 |
|
| |
|
| Transcription regulator |
| 0.535 | 1.067 |
|
| |
|
| Other |
| 0.910 | 1.055 | −2.385 | −2.462 | |
|
| Growth factor |
| 0.586 | 1.088 |
|
| |
|
| Other |
| 0.574 | −1.035 |
|
| |
|
| Transmembrane receptor |
| 0.049 | −1.414 | −0.244 | 0.256 | |
|
| Transmembrane receptor |
|
| ||||
|
| Transmembrane receptor |
| 0.249 | 1.134 |
|
| |
|
| Cytokine |
| 0.539 | 1.115 | −0.643 | −0.800 | |
Z-score < 2.0
Based on gene expression patterns, predictions are made on activation or inactivation of known upstream regulators. Absolute activation z-scores of higher than 2.0 are considered to be highly significant. We found more than twice as much regulators predicted to be activated as compared to inhibited. These tables show the predicted upstream regulators with an absolute z-score above 2.0 in detail—some are in fact complexes or groups. The prediction is opposed to the real measurement on the micro array (rightmost columns), as far as the respective genes have passed QC and is otherwise marked as “not measured”. Mean expression per group is given as logarithm of the intensity to base 2. Reasonably high expression values are in bold face. The column “regulation AR17” denotes if the respective gene is contained in the set of regulated genes (level = L1) or at least close to significance (level = L2/L3) which holds true for the minority of genes. Activation or inhibition is not necessarily reflected by significant change of gene expression, since processes not measurable on a micro array, like for example phosphorylation, are more likely to be responsible for that
Upstream regulator analysis with IPA: Predicted inactivated regulators
| IPA–prediction | Micro array analysis | ||||||
|---|---|---|---|---|---|---|---|
| Upstream regulator | Molecule type | z-score | FDR | FC | Mean AR17 | Mean noAR | Regulation AR17 [level] |
|
| G-protein coupled receptor |
| 0.061 | 1.308 | 0.389 | 0.001 | |
|
| Transcription regulator |
| 0.233 | 1.041 |
|
| |
|
| Enzyme |
| 0.797 | 1.048 | −0.588 | −0.655 | |
|
| Transcription regulator |
| 0.061 | −3.356 | −1.682 | 0.065 | |
|
| Growth factor |
|
| ||||
|
| Enzyme |
| 0.011 | 1.631 |
|
| [Up L3] |
|
| Transcription regulator |
| 0.560 | 1.033 |
|
| |
|
| Cytokine |
|
| ||||
|
| Cytokine |
| 0.009 | 1.812 | 0.062 | −0.796 | [Up L2] |
|
| Other |
|
| ||||
|
| Transcription regulator |
| 0.081 | −1.456 |
|
| |
|
| Transcription regulator |
| 0.168 | 1.119 | −1.622 | −1.785 | |
|
| Ligand-dependent nuclear receptor |
| 0.009 | −1.950 | −0.203 | 0.761 | [Down L2] |
|
| Transcription regulator |
| 0.021 | 1.358 |
|
| |
|
| Transporter |
| 0.752 | −1.087 | −2.019 | −1.899 | |
|
| Peptidase |
|
| ||||
|
| Other |
|
| ||||
|
| Phosphatase |
| 0.591 | 1.111 | −1.131 | −1.283 | |
|
| Transcription regulator |
|
| ||||
|
| Transcription regulator |
| 0.119 | −1.166 |
|
| |
Z-score < −2.0
Based on gene expression patterns, predictions are made on activation or inactivation of known upstream regulators. Absolute activation z-scores of higher than 2.0 are considered to be highly significant. We found more than twice as much regulators predicted to be activated as compared to inhibited. These tables show the predicted upstream regulators with an absolute z-score above 2.0 in detail—some are in fact complexes or groups. The prediction is opposed to the real measurement on the micro array (rightmost columns), as far as the respective genes have passed QC and is otherwise marked as “not measured”. Mean expression per group is given as logarithm of the intensity to base 2. Reasonably high expression values are in bold face. The column “regulation AR17” denotes if the respective gene is contained in the set of regulated genes (level = L1) or at least close to significance (level = L2/L3) which holds true for the minority of genes. Activation or inhibition is not necessarily reflected by significant change of gene expression, since processes not measurable on a micro array, like for example phosphorylation, are more likely to be responsible for that
Fig. 4Quantitative RT-PCR was performed to validate microarray analysis results. Gene expression analysis for 22 genes that showed deviant gene expression in microarray analysis has been performed using 2−ΔΔCq method. RT-qPCR has been performed using three technical replicates in a double determination. Gene expression in non-transfected 93RS2 cells was used as calibrator and therefore set as “1”. Data are presented as mean ± SEM. (standard error of the mean) and differences in mean values have been assessed with SPSS software; *p ≤ 0.05, n.d. not detectable
Fig. 5Illustration of eight genes and their association to known pathways in IPA. Green color denotes down-regulation, whereas red color denotes up-regulation
Fig. 6Hierarchical clustering of significantly regulated genes involved in cell adhesion. Clustering was done using “Pearson correlation” and “complete linkage”. The tree on the left reflects the distances between gene profiles based on this algorithm. AJ actin/intermediate = adherents junctions based on actin or intermediate filaments, TJ = tight junctions. Low significance: 1.5 < FC < 2.0 and/or FDR 0.01–0.05 High significance: FC > 2.0 and FDR < 0.01
Primer sequences
| Primer name | GenBank accession no. | Sequence (5′ ≥ 3′) | Amplicon length (bp) | RT-qPCR efficiency (%) | |
|---|---|---|---|---|---|
|
| NM_013476 | For | CACATCCTGCTCAAGGCGCTT | 181 | n.a. |
| (mouse) | Rev | CCCAGAAAGGATCTTGGGCAC | |||
| NM_012502 | 181 | n.a. | |||
| (rat) | |||||
| AR | NM_000044 | For | TATCCCAGTCCCACTTGTG | 592 | n.a. |
| Rev | TCTCTCCCAGTTCATTGAGG | ||||
|
| NM_053896 | For | TCAGACTTCGGGCTTGTAGC | 125 | 94.3 |
| Rev | GGGCTCTGAGCATTTAAGGC | ||||
|
| NM_001270681 | For | TGATGGAGGACACTATGACG | 188 | 105.8 |
| Rev | CATGGTGTTTACCTCGTTGC | ||||
|
| NM_139082 | For | CCATGCCCACTTTGGAATGC | 126 | 128.0 |
| Rev | TTCTGCTGCTGTCATGCTGG | ||||
|
| NM_080782 | For | CACAGGAGCAAAGTATGCCG | 125 | 135.1 |
| Rev | GCGAAGTCAAAGTTCCACCG | ||||
|
| NM_0011350009 | For | GGAGAACCTGGCAGTGATG | 118 | 99.9 |
| Rev | CACCCTTGGAACCTTTGTC | ||||
|
| NM_053367 | For | TTGGCACTCCTGGCACTATC | 124 | 102.2 |
| Rev | CGGGCATACTAGGCACAAAC | ||||
|
| NM_012551 | For | GTGGGAGAAAGTTTGCCAGG | 125 | 111.3 |
| Rev | GTAGGAAGAGAGGGAAGAGG | ||||
|
| NM_012712 | For | CAGCTTCCCCAGATTACCTG | 92 | 94.4 |
| Rev | CATTCGGCAAAAGATGACTG | ||||
|
| NM_012561 | For | TCCAGTACCAGGGCAAATG | 78 | 96.2 |
| Rev | TCTGATCCACCACACAAGTG | ||||
|
| NM_012567 | For | GTACGGGATTGAAGAGCACG | 119 | 105.5 |
| Rev | TGTACCACTGGATGAGCAGG | ||||
|
| NM_031682 | For | GAGGAAACTGCATATTTGCC | 106 | 110.5 |
| Rev | TTGACAGCCACATCTATACG | ||||
|
| NM_080771 | Rev | ACGGGTCAAGGTGTACTTCC | 96 | 100.3 |
| For | AAGGTATGCCAGCCACTACG | ||||
|
| NM_0123603 | Rev | TACATCCTGTCCGTTCAAGC | 67 | 108.0 |
| For | GCCGTTTCCTCAGTAAGTCC | ||||
|
| NM_031521 | Rev | ACGATGATGACTCCTCTACC | 150 | 94.1 |
| For | GCGCATTCTTGAACATGAGC | ||||
|
| NM_001107807 | Rev | TGGTGATGGTGGTGATGATC | 76 | 134.2 |
| For | CTGTGTCGGCTGATGAAGG | ||||
|
| NM_017232 | Rev | ACCGTGGTGAATGTATGAGC | 104 | 98.4 |
| For | TCTTGTCAGAAACTCAGGCG | ||||
|
| NM_001135249 | Rev | TCACCAAGGTCAGCAAAGCC | 125 | 141.9 |
| For | ACTGAACTTGTCCCACAGCC | ||||
|
| NM_012733 | Rev | CTTCAGTGTGTTCAGAAGGG | 117 | 87.9 |
| For | CTTGAACACTTGCTTGCAGG | ||||
|
| NM_001030021 | Rev | TTGCCTCTTATCTGCTGGCC | 110 | 103.4 |
| For | GTTGAGTCGTTCATCGTCCG | ||||
|
| NM_001034927 | Rev | TTCCTGCCCAAGTATCAGC | 108 | 111.5 |
| For | CCCAGAAGCGTCCTCTACAC | ||||
|
| NM_001013110 | Rev | TGAGGTCTTGCCACAGAAGG | 125 | 102.4 |
| For | CCACAACAGCATGAGAAGGG | ||||
|
| NM_001191840 | Rev | ACTACATCTCGGCACTCAGC | 101 | 106.5 |
| For | ACCCTCGTGCTCAAAGAAGC | ||||
|
| NM_013091 | Rev | AAAGAGGTGGAGGGTGAAGG | 128 | 101.7 |
| For | ACAGGATGACTGAAGCGTGG | ||||
|
| NM_017314 | Rev | GGCAAAGATCCAGGACAAGG | 100 | 99.4 |
| For | TTGTAGTCTGACAGGGTGCG | ||||
Sequence and RT-qPCR efficiency of primers used for the study
n.a. not applied